[Congressional Record Volume 166, Number 215 (Friday, December 18, 2020)]
[House]
[Page H7276]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]


                     EXECUTIVE COMMUNICATIONS, ETC.

   Under clause 2 of rule XIV, executive communications were taken from 
the Speaker's table and referred as follows:

       EC-5969. A letter from the Section Chief, Diversion Control 
     Division, Drug Enforcement Administration, Department of 
     Justice, transmitting the Department's Major interim final 
     rule -- Implementation of the Substance Use-Disorder 
     Prevention That Promotes Opioid Recovery and Treatment for 
     Patients and Communities Act of 2018: Dispensing and 
     Administering Controlled Substances for Medication-Assisted 
     Treatment [Docket No.: DEA-499] (RIN: 1117-AB55) received 
     December 14, 2020, pursuant to 5 U.S.C. 801(a)(1)(A); Public 
     Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on 
     Energy and Commerce.
       EC-5970. A letter from the Section Chief, Diversion Control 
     Division, Drug Enforcement Administration, Department of 
     Justice, transmitting the Department's Major final rule -- 
     Implementation of the Combat Methamphetamine Epidemic Act of 
     2005; Retail Sales; Notice of Transfers Following Importation 
     or Exportation [Docket No.: DEA-485] (RIN: 1117-AB05; 1117-
     AB06) received December 14, 2020, pursuant to 5 U.S.C. 
     801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); 
     to the Committee on Energy and Commerce.
       EC-5971. A letter from the Director, Legal Processing 
     Division, Internal Revenue Service, transmitting the 
     Service's Major final regulations -- Statutory Limitations on 
     Like-Kind Exchanges [TD 9935] (RIN: 1545-BP02) received 
     December 16, 2020, pursuant to 5 U.S.C. 801(a)(1)(A); Public 
     Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on 
     Ways and Means.
       EC-5972. A letter from the Regulations Writer -- Federal 
     Register Liaison, Office of Regulations and Reports 
     Clearance, Social Security Administration, transmitting the 
     Administration's Major final rule -- Revised Medical Criteria 
     for Evaluating Musculoskeletal Disorders [Docket No.: SSA-
     2006-0112] (RIN: 0960-AG38) received December 9, 2020, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); to the Committee on Ways and Means.
       EC-5973. A letter from the Regulations Coordinator, 
     Department of Health and Human Services, transmitting the 
     Department's Major final rule -- Medicare Program; CY 2021 
     Payment Policies Under the Physician Fee Schedule and Other 
     Changes to Part B Payment Policies; Medicare Shared Savings 
     Program Requirements; Medicaid Promoting Interoperability 
     Program Requirements for Eligible Professionals; Quality 
     Payment Program; Coverage of Opioid Use Disorder Services 
     Furnished by Opioid Treatment Programs; Medicare Enrollment 
     of Opioid Treatment Programs; Electronic Prescribing for 
     Controlled Substances for a Covered Part D Drug Under a 
     Prescription Drug Plan or an MA-PD Plan; etc. [CMS-1734-F, 
     CMS-1734-ICF, CMS-1744-F, CMS-5531-F, AND CMS-3401-IFC] (RIN: 
     0938-AU10, 0938-AU31, 0938-AU32, AND 0938-AU33) received 
     December 9, 2020, pursuant to 5 U.S.C. 801(a)(1)(A); Public 
     Law 104-121, Sec. 251; (110 Stat. 868); jointly to the 
     Committees on Energy and Commerce and Ways and Means.
       EC-5974. A letter from the Regulations Coordinator, 
     Department of Health and Human Services, transmitting the 
     Department's Major final rule -- Medicare Program: Hospital 
     Outpatient Prospective Payment and Ambulatory Surgical Center 
     Payment Systems and Quality Reporting Programs; New 
     Categories for Hospital Outpatient Department Prior 
     Authorization Process; Clinical Laboratory Fee Schedule: 
     Laboratory Date of Service Policy; Overall Hospital Quality 
     Star Rating Methodology; and Physician-Owned Hospitals [CMS-
     1736-FC, 1376-ICF] (RIN: 0938-AU12) received December 16, 
     2020, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, 
     Sec. 251; (110 Stat. 868); jointly to the Committees on 
     Energy and Commerce and Ways and Means.
       EC-5975. A letter from the Regulations Coordinator, 
     Department of Health and Human Services, transmitting the 
     Department's Major final rule -- Fraud and Abuse; Removal of 
     Safe Harbor Protection for Rebates Involving Prescription 
     Pharmaceuticals and Creation of New Safe Harbor Protection 
     for Certain Point-of-Sale Reductions in Price on Prescription 
     Pharmaceuticals and Certain Pharmacy Benefit Manager Service 
     Fees (RIN: 0936-AA08) received December 16, 2020, pursuant to 
     5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 
     Stat. 868); jointly to the Committees on Energy and Commerce 
     and Ways and Means.
       EC-5976. A letter from the Regulations Coordinator, 
     Department of Health and Human Services, transmitting the 
     Department's Major final rule -- Medicare and State Health 
     Care Programs: Fraud and Abuse; Revisions to Safe Harbors 
     Under the Anti-Kickback Statute, and Civil Monetary Penalty 
     Rules Regarding Beneficiary Inducements (RIN: 0936-AA10) 
     received December 16, 2020, pursuant to 5 U.S.C. 
     801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); 
     jointly to the Committees on Energy and Commerce, Ways and 
     Means, and the Judiciary.

                          ____________________